Agreement opens Japan to Indian generics
This article was originally published in Scrip
Executive Summary
India and Japan have signed a Comprehensive Economic Partnership Agreement (CEPA), which offers a gamut of bilateral benefits including duty concessions for products across sectors and improved access to the Japanese pharmaceutical market for Indian firms.